Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma

Por Issa, Mark E., Takhsha, Farnaz Sedigheh, Chirumamilla, Chandra Sekhar, Perez-Novo, Claudina, Vanden Berghe, Wim, Cuendet, Muriel
Publicado no Clin Epigenetics (2017)

Imidazo[2,1-b]benzothiazol Derivatives as Potential Allosteric Inhibitors of the Glucocorticoid Receptor

Por Christodoulou, Michael S., Dapiaggi, Federico, Ghiringhelli, Francesca, Pieraccini, Stefano, Sironi, Maurizio, Lucafò, Marianna, Curci, Debora, Decorti, Giuliana, Stocco, Gabriele, Chirumamilla, Chandra Sekhar, Vanden Berghe, Wim, Balaguer, Patrick, Michel, Benoît Y., Burger, Alain, Beccalli, Egle M., Passarella, Daniele, Martinet, Nadine
Publicado no ACS Med Chem Lett (2018)

Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma

Por Hassannia, Behrouz, Wiernicki, Bartosz, Ingold, Irina, Qu, Feng, Van Herck, Simon, Tyurina, Yulia Y., Bayır, Hülya, Abhari, Behnaz A., Angeli, Jose Pedro Friedmann, Choi, Sze Men, Meul, Eline, Heyninck, Karen, Declerck, Ken, Chirumamilla, Chandra Sekhar, Lahtela-Kakkonen, Maija, Van Camp, Guy, Krysko, Dmitri V., Ekert, Paul G., Fulda, Simone, De Geest, Bruno G., Conrad, Marcus, Kagan, Valerian E., Vanden Berghe, Wim, Vandenabeele, Peter, Vanden Berghe, Tom
Publicado no J Clin Invest (2018)